APSMNF

· Apsen Farmaceutica S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APSMNF, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia [Phase 3]